Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance …
Over the last 12 months, insiders at Codexis, Inc. have bought $3.82M and sold $42,168 worth of Codexis, Inc. stock.
On average, over the past 5 years, insiders at Codexis, Inc. have bought $1.99M and sold $3.56M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Opaleye Management Inc. (10 percent owner) — $19.11M.
The last purchase of 25,000 shares for transaction amount of $72,720 was made by Opaleye Management Inc. (10 percent owner) on 2024‑10‑25.
2024-10-25 | 10 percent owner | 25,000 0.0311% | $2.91 | $72,720 | 0.00% | |||
2024-09-25 | 10 percent owner | 5,000 0.0069% | $2.86 | $14,291 | +8.46% | |||
2024-09-24 | 10 percent owner | 80,000 0.1134% | $2.94 | $234,856 | +5.60% | |||
2024-09-23 | 10 percent owner | 45,000 0.064% | $2.94 | $132,485 | +8.73% | |||
2024-09-20 | 10 percent owner | 1.05M 1.4443% | $3.01 | $3.18M | +1.94% | |||
2024-09-18 | 10 percent owner | 61,000 0.0875% | $3.16 | $192,992 | +1.61% | |||
2023-11-15 | Sale | director | 20,000 0.0289% | $2.11 | $42,168 | +47.50% | ||
2023-09-11 | Chief Operating Officer | 9,000 0.0126% | $1.72 | $15,479 | +64.20% | |||
2023-09-08 | See Remarks | 58,479 0.0841% | $1.73 | $100,952 | +68.31% | |||
2023-09-08 | Chief Financial Officer | 11,650 0.0165% | $1.70 | $19,856 | +68.31% | |||
2023-09-08 | See Remarks | 11,834 0.0167% | $1.70 | $20,065 | +68.31% | |||
2023-04-18 | Sale | director | 35,714 0.0539% | $4.14 | $147,874 | -34.74% | ||
2023-04-17 | Sale | director | 35,714 0.0529% | $4.24 | $151,377 | -37.44% | ||
2023-03-16 | Sale | director | 35,714 0.054% | $4.11 | $146,681 | -34.04% | ||
2023-03-15 | Sale | director | 35,714 0.0533% | $4.09 | $146,131 | -34.62% | ||
2023-03-08 | Sale | See Remarks | 26,987 0.0411% | $4.56 | $122,931 | -40.09% | ||
2023-03-08 | Sale | Chief Operating Officer | 8,258 0.0126% | $4.56 | $37,617 | -40.09% | ||
2023-03-08 | Sale | See remarks | 7,686 0.0117% | $4.56 | $35,011 | -40.09% | ||
2023-03-07 | Sale | See Remarks | 28,088 0.0426% | $4.60 | $129,281 | -40.87% | ||
2023-03-07 | Sale | Chief Operating Officer | 8,596 0.013% | $4.60 | $39,565 | -40.87% |
Opaleye Management Inc. | 10 percent owner | 8545000 10.5004% | $3.97 | 6 | 0 | |
NICOLS JOHN J | director | 783965 0.9634% | $3.97 | 4 | 31 | <0.0001% |
DILLY STEPHEN GEORGE | See Remarks | 438878 0.5393% | $3.97 | 1 | 2 | |
SHAW ALAN | President and CEO | 202000 0.2482% | $3.97 | 1 | 12 | +25.75% |
Ryali Sriram | Chief Financial Officer | 123441 0.1517% | $3.97 | 1 | 0 |
BlackRock | $23.09M | 9.38 | 6.61M | -8.08% | -$2.03M | <0.01 | |
Nantahala Capital Management Llc | $15.57M | 6.32 | 4.46M | -2.85% | -$457,277.24 | 0.73 | |
Fidelity Investments | $15.47M | 6.28 | 4.43M | +1.54% | +$234,447.73 | <0.01 | |
The Vanguard Group | $14.86M | 6.04 | 4.26M | +3.14% | +$452,907.76 | <0.0001 | |
Baillie Gifford Co | $12.02M | 4.88 | 3.45M | +0.77% | +$91,493.84 | 0.01 |